Results 201 to 210 of about 2,838,728 (307)
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
British Journal of Pharmacology, EarlyView.Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
Digestive Endoscopy, EarlyView.ABSTRACT Objectives Endoscopic retrograde cholangiopancreatography (ERCP) is frequently indicated in patients who underwent Roux‐en‐Y gastric bypass (RYGB) surgery. Endoscopic ultrasound‐directed ERCP (EDGE) is a technique that is used to create a gastro‐gastrostomy by placing a lumen‐apposing metal stent (LAMS) between the gastric pouch and the ...
A. G. Overdevest +10 more
wiley +1 more source
Making Advanced Therapies Affordable and Accessible: Two Strategic Approaches
Developing World Bioethics, EarlyView.ABSTRACT This article explores two complementary strategies for addressing the affordability and access challenges facing advanced therapies. As high development costs and limited market access have led to the withdrawal of several therapies, the article examines how these barriers create ‘valleys of death’ that prevent innovation from reaching ...
Ubaka Ogbogu, Lauren Albrecht
wiley +1 more source
circ_UTRN inhibits ferroptosis of ARJ21 cells to attenuate acute pancreatitis progression by regulating the miR-760-3p/FOXO1/GPX4 axis [PDF]
Lanlan Wei +4 more
openalex +1 more source